
    
      This study is designed as an 8-week, single-center, randomized, assessor- and
      analyst-blinded, controlled trial with two parallel interventional groups in a 1:1
      allocation.

      Patients will be recruited from outpatient clinics of the Eye and ENT Hospital of Fudan
      University in Shanghai, qualified with well-trained doctors, staff and required facilities
      for this clinical trial.
    
  